by Jacques Lemoisson | Jan 11, 2021
11 million people are in containment in China as of today, pandemic figures in the USA are skyrocketing and the EU is managing logistical issues. As written in the Lancet report, at 6 months after acute infection, COVID-19 survivors were mainly troubled with fatigue...
by Jacques Lemoisson | Jan 11, 2021
This brings to 34 the number of confirmed infections from a variant strain in Japan. Of these, three are cases in which the person did not arrive from overseas, including two cases of the U.K. strain found on Sunday. This is not a real issue till the vaccines are...
by Jacques Lemoisson | Jan 7, 2021
As I pointed out in 2020, in my outlook and beginning of this month, we know what are these vaccines but politicians are not in hurry to try, and more importantly, neither the heath staffs around the globe… In the US, a survey released last month by the Kaiser...
by Jacques Lemoisson | Jan 6, 2021
I pointed out many times the danger around the gap of temporality between what the markets priced and the reality. It seems that the markets are thinking to be immune… All around the world, production and logistic issues are joining the mistrust regarding...
by Jacques Lemoisson | Jan 5, 2021
The FDA, after the WHO, is warning false results from Covid tests… Not the right timing when Governments (populists one in first) are all-in with vaccines. Billions would have been more efficient in new generation of tests and treatments. Health policies are...
by Jacques Lemoisson | Jan 3, 2021
The mistrust about vaccines is important and spreading fast. Credibility is key and this weekend was catastrophic: 1 – the U.K. proposes to mix vaccines 2 – the U.K. postpones the second shot when the vaccine was created and validated with 2 shots and 3...
